Bell, Jessica L <br/><br/>
IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2015 
 - 1285-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2014.55.9880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--genetics<br/>Cell Line, Tumor<br/>Databases, Genetic<br/>Disease-Free Survival<br/>Gene Amplification<br/>Gene Dosage<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Predisposition to Disease<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>N-Myc Proto-Oncogene Protein<br/>Neoplasm Staging<br/>Neuroblastoma--genetics<br/>Nuclear Proteins--genetics<br/>Oligonucleotide Array Sequence Analysis<br/>Oncogene Proteins--genetics<br/>Phenotype<br/>Proportional Hazards Models<br/>RNA, Messenger--analysis<br/>RNA-Binding Proteins--genetics<br/>Risk Factors<br/>Time Factors<br/>Transfection<br/>Treatment Outcome